Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.600 | None | 0.971 | 77 | 0 | 1979 | 2020 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.400 | None | 0.989 | 68 | 0 | 1974 | 2020 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
disease | 0.500 | None | 0.977 | 64 | 0 | 1984 | 2020 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.400 | None | 0.973 | 58 | 0 | 1989 | 2020 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.360 | None | 1.000 | 58 | 0 | 1989 | 2019 | ||||||||
|
ATPase copper transporting beta | 0.529 | 0.654 | 4.8E-30 |
|
disease | 0.300 | None | 1.000 | 51 | 0 | 2000 | 2014 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.800 | None | 0.970 | 40 | 0 | 1987 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.600 | None | 0.972 | 40 | 0 | 1987 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.300 | None | 1.000 | 40 | 0 | 2000 | 2015 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.370 | None | 1.000 | 40 | 0 | 1988 | 2015 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.400 | None | 0.981 | 35 | 0 | 1991 | 2020 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.400 | None | 0.993 | 35 | 0 | 1988 | 2019 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.400 | None | 0.986 | 35 | 0 | 1991 | 2019 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.300 | None | 1.000 | 35 | 0 | 1991 | 2018 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.300 | None | 1.000 | 35 | 0 | 1991 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.600 | None | 0.974 | 33 | 0 | 1991 | 2019 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.400 | None | 0.978 | 33 | 0 | 1986 | 2019 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
phenotype | 0.400 | None | 1.000 | 31 | 0 | 1967 | 2018 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.400 | None | 0.978 | 29 | 0 | 1983 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.300 | None | 1.000 | 29 | 0 | 1997 | 2018 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.600 | None | 0.990 | 28 | 0 | 2007 | 2020 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.800 | strong | 0.985 | 28 | 0 | 1993 | 2020 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.300 | None | 1.000 | 25 | 0 | 1995 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.330 | None | 1.000 | 25 | 0 | 1995 | 2019 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.310 | None | 1.000 | 24 | 0 | 1995 | 2018 |